HBSAG DECLINE DURING PEGINTERFERON ALFA-2B THERAPY FOR HBEAG-POSITIVE CHRONIC HEPATITIS B DEPENDS ON HBV GENOTYPE: RELATION TO SUSTAINED RESPONSE
dc.contributor.author | Sonneveld, Milan J. | |
dc.contributor.author | Rijckborst, Vincent | |
dc.contributor.author | Senturk, Hakan | |
dc.contributor.author | Zeuzem, Stefan | |
dc.contributor.author | Akarca, Ulus S. | |
dc.contributor.author | Simon, Krzysztof | |
dc.contributor.author | Gerken, Guido | |
dc.contributor.author | Boucher, Charles A. | |
dc.contributor.author | Hansen, Bettina E. | |
dc.contributor.author | Janssen, Harry L. | |
dc.date.accessioned | 2019-10-27T21:14:19Z | |
dc.date.available | 2019-10-27T21:14:19Z | |
dc.date.issued | 2010 | |
dc.department | Ege Üniversitesi | en_US |
dc.description | 61st Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases -- OCT 29-NOV 02, 2010 -- Boston, MA | en_US |
dc.description.sponsorship | Amer Assoc Study Liver Dis | en_US |
dc.identifier.endpage | 540A | en_US |
dc.identifier.issn | 0270-9139 | |
dc.identifier.issn | 1527-3350 | |
dc.identifier.issue | 4 | en_US |
dc.identifier.startpage | 539A | en_US |
dc.identifier.uri | https://hdl.handle.net/11454/43366 | |
dc.identifier.volume | 52 | en_US |
dc.identifier.wos | WOS:000288775600446 | en_US |
dc.identifier.wosquality | Q1 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.language.iso | en | en_US |
dc.publisher | Wiley | en_US |
dc.relation.ispartof | Hepatology | en_US |
dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.title | HBSAG DECLINE DURING PEGINTERFERON ALFA-2B THERAPY FOR HBEAG-POSITIVE CHRONIC HEPATITIS B DEPENDS ON HBV GENOTYPE: RELATION TO SUSTAINED RESPONSE | en_US |
dc.type | Conference Object | en_US |